A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patients
Background: This study was aimed to measure the serum levels of YKL-40 among early and late rheumatoid arthritis (RA) patients along with other disease activity measures in RA patients. Materials and Methods: It was a cross-sectional study involving 152 RA patients based on the 1987 American College...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=3;spage=200;epage=205;aulast=Narayan |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832544227948494848 |
---|---|
author | Vinod Narayan Vasanthi Pallinti Nalini Ganesan |
author_facet | Vinod Narayan Vasanthi Pallinti Nalini Ganesan |
author_sort | Vinod Narayan |
collection | DOAJ |
description | Background: This study was aimed to measure the serum levels of YKL-40 among early and late rheumatoid arthritis (RA) patients along with other disease activity measures in RA patients.
Materials and Methods: It was a cross-sectional study involving 152 RA patients based on the 1987 American College of Rheumatology criteria for the diagnosis of RA and 68 age- and sex-matched healthy controls. The patient group was further subdivided into 75 early (<2 years disease duration) and 77 late (>2 years) RA patients based on the duration of the disease. Clinical examination was performed on RA patients, and traditional markers to measure the disease activity such as Disease Activity Score (DAS)-28, Visual Analog Score (VAS), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), anti-cyclic citrullinated peptide (CCP), and rheumatoid factor (RF) were assessed. Serum YKL-40 level was measured using ELISA method. All the values were expressed as median (25th–75th percentile).
Results: In our study, there was a significant increase in serum YKL-40 level in RA patients (200.8 [141.24–282.7] ng/ml) compared to healthy controls (82.2 [49.01–123.78] ng/ml) with P < 0.001. There was no significant difference in serum YKL-40 levels among early and late RA patients. The traditional inflammatory markers such as ESR, CRP, and measures of disease activity such as DAS-28 and VAS were significantly increased in late RA patients than early RA (P < 0.001). Serum YKL-40 levels were not correlated with disease activity measures such as DAS-28, VAS, CRP, and ESR in RA patients.
Conclusion: Serum YKL-40 level was significantly higher in RA. However there was no difference between early and late RA. It does not correlate with measures of disease activity. |
format | Article |
id | doaj-art-d0c4cc591b754d8f86fd8de01fc83537 |
institution | Kabale University |
issn | 0973-3698 0973-3701 |
language | English |
publishDate | 2019-01-01 |
publisher | SAGE Publishing |
record_format | Article |
series | Indian Journal of Rheumatology |
spelling | doaj-art-d0c4cc591b754d8f86fd8de01fc835372025-02-03T10:52:11ZengSAGE PublishingIndian Journal of Rheumatology0973-36980973-37012019-01-0114320020510.4103/injr.injr_44_19A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patientsVinod NarayanVasanthi PallintiNalini GanesanBackground: This study was aimed to measure the serum levels of YKL-40 among early and late rheumatoid arthritis (RA) patients along with other disease activity measures in RA patients. Materials and Methods: It was a cross-sectional study involving 152 RA patients based on the 1987 American College of Rheumatology criteria for the diagnosis of RA and 68 age- and sex-matched healthy controls. The patient group was further subdivided into 75 early (<2 years disease duration) and 77 late (>2 years) RA patients based on the duration of the disease. Clinical examination was performed on RA patients, and traditional markers to measure the disease activity such as Disease Activity Score (DAS)-28, Visual Analog Score (VAS), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), anti-cyclic citrullinated peptide (CCP), and rheumatoid factor (RF) were assessed. Serum YKL-40 level was measured using ELISA method. All the values were expressed as median (25th–75th percentile). Results: In our study, there was a significant increase in serum YKL-40 level in RA patients (200.8 [141.24–282.7] ng/ml) compared to healthy controls (82.2 [49.01–123.78] ng/ml) with P < 0.001. There was no significant difference in serum YKL-40 levels among early and late RA patients. The traditional inflammatory markers such as ESR, CRP, and measures of disease activity such as DAS-28 and VAS were significantly increased in late RA patients than early RA (P < 0.001). Serum YKL-40 levels were not correlated with disease activity measures such as DAS-28, VAS, CRP, and ESR in RA patients. Conclusion: Serum YKL-40 level was significantly higher in RA. However there was no difference between early and late RA. It does not correlate with measures of disease activity.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=3;spage=200;epage=205;aulast=Narayananti-cyclic citrullinated peptideearly and late rheumatoid arthritisrheumatoid arthritisrheumatoid factorykl-40 |
spellingShingle | Vinod Narayan Vasanthi Pallinti Nalini Ganesan A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patients Indian Journal of Rheumatology anti-cyclic citrullinated peptide early and late rheumatoid arthritis rheumatoid arthritis rheumatoid factor ykl-40 |
title | A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patients |
title_full | A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patients |
title_fullStr | A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patients |
title_full_unstemmed | A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patients |
title_short | A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patients |
title_sort | study of serum ykl 40 and its correlation with traditional biomarkers in rheumatoid arthritis patients |
topic | anti-cyclic citrullinated peptide early and late rheumatoid arthritis rheumatoid arthritis rheumatoid factor ykl-40 |
url | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=3;spage=200;epage=205;aulast=Narayan |
work_keys_str_mv | AT vinodnarayan astudyofserumykl40anditscorrelationwithtraditionalbiomarkersinrheumatoidarthritispatients AT vasanthipallinti astudyofserumykl40anditscorrelationwithtraditionalbiomarkersinrheumatoidarthritispatients AT naliniganesan astudyofserumykl40anditscorrelationwithtraditionalbiomarkersinrheumatoidarthritispatients AT vinodnarayan studyofserumykl40anditscorrelationwithtraditionalbiomarkersinrheumatoidarthritispatients AT vasanthipallinti studyofserumykl40anditscorrelationwithtraditionalbiomarkersinrheumatoidarthritispatients AT naliniganesan studyofserumykl40anditscorrelationwithtraditionalbiomarkersinrheumatoidarthritispatients |